Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention


  Free Subscription


1 Ann Intern Med
1 BMC Gastroenterol
1 Cancer
3 Hepatology
1 J Infect Dis
1 J Med Virol
2 MMWR Morb Mortal Wkly Rep
1 PLoS One
1 PLoS Pathog
1 Transplant Proc
1 Virology

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Ann Intern Med

  1. GREBELY J, Dore GJ, Altice FL, Conway B, et al
    Reinfection and Risk Behaviors After Treatment of Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy : A Cohort Study.
    Ann Intern Med. 2022 Aug 9. doi: 10.7326/M21-4119.
    PubMed         Abstract available

    BMC Gastroenterol

  2. LIM ZZ, Teo JS, Tan AC, Lim TO, et al
    Awareness and treatment of chronic hepatitis B in Malaysia-findings from a community-based screening campaign.
    BMC Gastroenterol. 2022;22:374.
    PubMed         Abstract available


    Hepatitis C infection and advanced hepatocellular carcinoma-To treat or not to treat?
    Cancer. 2022 Aug 9. doi: 10.1002/cncr.34408.


  4. WU Y, Hao X, Wei H, Sun R, et al
    TIGIT blockade elicits potent anti-tumor immunity in naturally occurring hepatitis B virus-related hepatocellular carcinoma in mice.
    Hepatology. 2022 Aug 8. doi: 10.1002/hep.32715.
    PubMed         Abstract available

  5. TRUDEAU S, Mendiratta V, Dababneh Y, Hollingsworth J, et al
    Letter to the Editor: Successful treatment of multidrug resistant hepatitis C after >12 months of continuous therapy with direct-acting antivirals.
    Hepatology. 2022 Jul 27. doi: 10.1002/hep.32688.

  6. PAL S, Dey D, Chakraborty BC, Nandi M, et al
    Diverse facets of MDSC in different phases of chronic HBV infection: Impact on HBV-specific T-cell response and homing.
    Hepatology. 2022;76:759-774.
    PubMed         Abstract available

    J Infect Dis

  7. GARDNER AR, Ma Y, Bacchetti P, Price JC, et al
    Longitudinal Assessment of the Enhanced Liver Fibrosis Score in the Era of Contemporary HIV and Hepatitis C Virus Treatment.
    J Infect Dis. 2022 Aug 11. pii: 6650396. doi: 10.1093.
    PubMed         Abstract available

    J Med Virol

  8. SARFARAZ N, Somarowthu S, Bouchard MJ
    The Interplay of Long Non-Coding RNAs and Hepatitis B Virus.
    J Med Virol. 2022 Aug 9. doi: 10.1002/jmv.28058.
    PubMed         Abstract available

    MMWR Morb Mortal Wkly Rep

  9. QuickStats: Percentage* of Adults(dagger) Aged >/=18 Years with Current Hepatitis C Virus Infection,( section sign) by Health Insurance Coverage( paragraph sign) - National Health and Nutrition Examination Survey, United States, January 2017-March 202
    MMWR Morb Mortal Wkly Rep. 2022;71:1035.

  10. THOMPSON WW, Symum H, Sandul A, Gupta N, et al
    Vital Signs: Hepatitis C Treatment Among Insured Adults - United States, 2019-2020.
    MMWR Morb Mortal Wkly Rep. 2022;71:1011-1017.
    PubMed         Abstract available

    PLoS One

  11. SCHORR O, Blach S, Thurnheer C, Ruis C, et al
    Modelling the microelimination of chronic hepatitis C in the canton of Bern, Switzerland: Reaching the Swiss Hepatitis Strategy goals despite the impact of the COVID 19 pandemic.
    PLoS One. 2022;17:e0272518.
    PubMed         Abstract available

    PLoS Pathog

  12. HONG X, Menne S, Hu J
    Constrained evolution of overlapping genes in viral host adaptation: Acquisition of glycosylation motifs in hepadnaviral precore/core genes.
    PLoS Pathog. 2022;18:e1010739.
    PubMed         Abstract available

    Transplant Proc

  13. OKUMURA K, Sogawa H, Samson D, Butler J, et al
    Improving Liver Transplant Outcomes for Hepatitis C Virus Hepatocellular Carcinoma in the Direct-Acting Antiviral Therapy Era.
    Transplant Proc. 2022 Aug 4. pii: S0041-1345(22)00445.
    PubMed         Abstract available


  14. TARNOW G, Matrenec R, Oropeza CE, Maienschein-Cline M, et al
    Distinct phenotypic spectra of hepatocellular carcinoma in liver-specific tumor suppressor-deficient hepatitis B virus transgenic mice.
    Virology. 2022;574:84-95.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.